Scholar Rock Holding Corporation
10/14/2025 | Press release | Distributed by Public on 10/14/2025 04:09
Material Event (Form 8-K)
Item 8.01. Other Events.
On October 10, 2025, Novo Nordisk informed Scholar Rock Holding Corporation (the "Company") that, following the Form FDA 483 issued to Catalent Indiana, LLC (owned by Novo Nordisk) on July 14, 2025, the U.S. Food and Drug Administration has determined that the inspection classification of this facility is "official action indicated".
Scholar Rock Holding Corporation published this content on October 14, 2025, and is solely responsible for the information contained herein. Distributed via Edgar on October 14, 2025 at 10:09 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]